Mabwell (Shanghai) Bioscience (688062.SS) Earnings Analysis
Mabwell (Shanghai) Bioscience (688062.SS) has no confirmed upcoming earnings date. Trailing P/E -14.35.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688062.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 688062.SS. This page updates as the calendar is published.
688062.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-27 | -0.93 CNY | n/a | n/a | n/a |
| 2025-10-30 | -0.11603 CNY | n/a | n/a | n/a |
| 2025-06-30 | -0.64958 CNY | n/a | n/a | n/a |
| 2025-04-28 | -0.73 CNY | n/a | n/a | n/a |
| 2024-12-31 | -0.87545 CNY | n/a | n/a | n/a |
| 2024-08-30 | -0.59891 CNY | n/a | n/a | n/a |
688062.SS valuation and analyst view
| Trailing P/E | -14.35 |
|---|---|
| Trailing EPS | -2.31017 CNY |
| Price / book | 123.65 |
| Dividend yield | 0.00% |
| Market cap | 13.46B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Mabwell (Shanghai) Bioscience (688062.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 688062.SS. This page updates as the calendar is published.
Did 688062.SS beat earnings last quarter?
Consensus estimate data was not available for 688062.SS's 2026-02-27 report.
What is 688062.SS's current P/E ratio and EPS?
688062.SS trades at a trailing P/E of -14.35 on trailing EPS of -2.3101740112001017 CNY.
What do analysts rate 688062.SS?
688062.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.